Lead Poisoning

Introduction & Sources - The Silent Spreader

• Lead poisoning: A preventable environmental illness affecting multiple organ systems, especially the developing brain; often asymptomatic. Blood Lead Level (BLL) > 3.5 µg/dL (CDC), WHO > 5 µg/dL.
• Common Sources (India):
  • Old paint, dust, soil
  • Water (lead pipes)
  • Traditional remedies (Ayurvedic, Surma, Sindoor) 📌
  • Toys, batteries (informal recycling)
  • Contaminated food/spices (e.g., turmeric adulterated with lead chromate)
  • Parental occupation (take-home exposure)

⭐ No level of lead exposure is considered safe; even low levels affect neurodevelopment.

Toxicokinetics & Pathophysiology - How Lead Harms

• Absorption:
  • GIT: Children absorb ~50% (↑ with Fe/Ca/Zn deficiency).
  • Lungs: Inhalation (fumes, organic lead).
• Distribution:
  • Blood: 99% bound to RBCs.
  • Tissues: Brain (crosses BBB), liver, kidney.
  • Bone: Long half-life (~20-30 yrs), mimics Ca²⁺.
  • Crosses placenta.
• Excretion: Primarily renal.
• Mechanism of Harm:
  • Enzyme inhibition (sulfhydryl groups):
    • ↓ Heme synthesis: ALAD & Ferrochelatase inhibition → ↑ ALA, ↑ FEP/ZPP.
  • Ionic mimicry: Competes with Ca²⁺, Zn²⁺, Fe²⁺.
  • Oxidative stress.
  • Neurotoxicity: Disrupts BBB, neurotransmission.
  • Nephrotoxicity: Proximal tubule damage.
  • Hematotoxicity: Microcytic anemia, basophilic stippling.

⭐ Lead interferes with heme synthesis by inhibiting δ-aminolevulinic acid dehydratase (ALAD) and ferrochelatase.

Clinical Manifestations - Symptoms Unveiled

• Early/Low Exposure (Often Subtle):
  • Neurobehavioral: Irritability, hyperactivity, ↓attention span, developmental delays, ↓IQ.
  • GIT: Vague abdominal discomfort, constipation, anorexia.
• Moderate/Progressive Exposure:
  • CNS: Lethargy, headache.
  • GIT: Intermittent, severe abdominal pain (lead colic), vomiting.
  • Hematologic: Microcytic anemia, pallor.
• Severe Exposure/Encephalopathy (Medical Emergency!):
  • CNS: Persistent vomiting, ataxia, altered sensorium (confusion, stupor), seizures, papilledema, coma.
  • Peripheral neuropathy (e.g., wrist drop) - more common in adults.
• Other Systems:
  • Renal: Fanconi-like syndrome, chronic nephropathy.
  • Skeletal: "Lead lines" on long bone X-rays.
  • Dental: Burton's line (bluish gingival line) - rare in children.

⭐ Basophilic stippling of red blood cells is a characteristic, though not pathognomonic, finding in lead poisoning.

Diagnosis & Management - Finding & Fixing

• Diagnosis:
  • Blood Lead Level (BLL): Gold standard (venous sample).
  • CDC Reference: < 3.5 µg/dL. Action if BLL ≥ 3.5 µg/dL.
  • Other: ↑Erythrocyte protoporphyrin (EPP), X-ray "lead lines".
• Management Strategy:
  1. Source Removal: Crucial first step. Environmental inspection.
  2. Nutritional Support: Adequate Iron, Calcium, Vitamin C.
  3. Chelation Therapy (if indicated by BLL):
     • BLL 3.5-44 µg/dL: Environmental/Nutritional intervention, monitoring.
     • BLL 45-69 µg/dL (asymptomatic): Oral Succimer (DMSA).
     • BLL ≥ 70 µg/dL or Encephalopathy:
       • Hospitalize; IV/IM Dimercaprol (BAL) then CaNa2EDTA.
       • 📌 BAL given first to prevent lead redistribution to brain.

⭐ CaNa2EDTA mobilizes lead from bone; ensure adequate hydration and renal function monitoring due to nephrotoxicity risk.

High‑Yield Points - ⚡ Biggest Takeaways

• Common sources: Old paint, batteries, contaminated water, some traditional medicines.
• Key features: Neurodevelopmental delay, abdominal colic, microcytic anemia with basophilic stippling, Burton's line, X-ray lead lines.
• Diagnosis: Blood Lead Level (BLL) is gold standard; ↑ Free Erythrocyte Protoporphyrin (FEP)/Zinc Protoporphyrin (ZPP).
• Management: Immediate source removal. Chelation therapy (e.g., Succimer, CaNa2EDTA) for BLL ≥45 µg/dL.
• Severe cases (BLL ≥70 µg/dL or encephalopathy): BAL (Dimercaprol) + CaNa2EDTA.
• Long-term risks: Irreversible cognitive deficits and behavioral problems.
• Prevention: Screening at-risk populations and environmental hazard reduction is key.